Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2028

Conditions
Freezing of GaitParkinson Disease
Interventions
DEVICE

Spinal Cord Stimulation

SCS is an established treatment for chronic neuropathic pain and the implantation procedure in this study follows the conventional clinical approach. Under local anaesthesia, a lead electrode is positioned in the spinal epidural space at the Th8-Th10 vertebral levels. The electrode is then connected to an external stimulator (implantable pulse generator, IPG), used for the 3-week external trial stimulation. Upon completion of the core trial, the electrode may either be removed or connected to an internal IPG, after extensive counselling and dependent on the FOG outcome and patient's preference. A subsequent long-term open label phase will evaluate the long-term efficacy and safety of SCS on FOG, with a follow-up period of six months. Electrophysiological recordings of the dorsal spinal cord will be conducted at the end of the external trial stimulation and at the 6-month follow-up.

OTHER

Spinal electrophysiological recordings

The sole purpose of the control groups in this study, is to facilitate the interpretation of spinal cord electrophysiological characteristics in PD freezers by providing a comparison with individuals without the condition.

Trial Locations (1)

3000

RECRUITING

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER